Profarma Distribuidora de Produtos Farmacêuticos S.A. (BVMF:PFRM3)

BVMF:PFRM3 Balance Sheet

Financials in millions BRL. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	487.77	235.12	229.55	193.74	183.26	188.52
Cash & Short-Term Investments	487.77	235.12	229.55	193.74	183.26	188.52
Cash Growth	97.83%	2.43%	18.48%	5.72%	-2.79%	-49.30%
Accounts Receivable	2,367	1,556	1,394	1,187	1,044	831.43
Other Receivables	412.43	567.56	454.96	600.78	498.23	448.16
Receivables	2,779	2,124	1,849	1,788	1,542	1,280
Inventory	2,147	2,095	1,820	1,528	1,236	1,085
Prepaid Expenses	-	8.48	-	10.43	6.61	8.72
Other Current Assets	298.98	31.71	121.39	19.66	13.16	20.55
Total Current Assets	5,713	4,494	4,020	3,539	2,980	2,582
Property, Plant & Equipment	894.59	824.33	674.18	535.59	507	519.02
Long-Term Investments	1.89	1.86	2.04	2.01	1.99	-
Goodwill	476.14	479.82	486.28	483.16	488.01	495.02
Other Intangible Assets	223.83	156.24	143.04	134.74	131.47	129.31
Long-Term Deferred Tax Assets	341.26	226.78	234.13	184.1	177.08	163.7
Other Long-Term Assets	331.73	51.19	56.48	58.96	78.96	143.84
Total Assets	7,983	6,234	5,616	4,938	4,365	4,033

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	2,917	2,622	2,195	1,820	1,486	1,286
Accrued Expenses	267.37	248.06	220.22	69.29	147.6	119.73
Current Portion of Long-Term Debt	650.15	311.14	248.54	206.28	131.02	117.65
Current Portion of Leases	120.5	115.94	110.67	92.51	90.91	89.18
Current Income Taxes Payable	3.04	2.71	1.7	106.65	0.18	0.15
Current Unearned Revenue	43.82	54.35	109.51	49.37	21.51	46.54
Other Current Liabilities	158.93	130.95	103.14	102.07	79.48	57.22
Total Current Liabilities	4,161	3,485	2,989	2,447	1,956	1,717
Long-Term Debt	693.03	563.53	551.18	573.63	532.65	440.8
Long-Term Leases	434.29	411.18	336.32	271.28	269.62	299.25
Long-Term Deferred Tax Liabilities	85.46	54.48	82.12	40.22	41.42	38.06
Other Long-Term Liabilities	923.83	84.6	71.66	67.13	54.33	62.02
Total Liabilities	6,298	4,599	4,030	3,399	2,854	2,557

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	1,059	1,059	918.66	1,044	1,044	1,044
Retained Earnings	193.13	124.05	224.15	180.07	156.97	97.35
Treasury Stock	-16.37	-16.37	-16.37	-16.37	-16.37	-16.37
Comprehensive Income & Other	207.43	179.39	176.66	40.98	6.74	-38.58
Total Common Equity	1,443	1,346	1,303	1,248	1,191	1,086
Minority Interest	242.08	289.83	282.72	290.68	319.58	389.82
Shareholders' Equity	1,685	1,636	1,586	1,539	1,511	1,476
Total Liabilities & Equity	7,983	6,234	5,616	4,938	4,365	4,033

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	1,898	1,402	1,247	1,144	1,024	946.88
Net Cash (Debt)	-1,410	-1,167	-1,017	-949.96	-840.94	-758.37
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-11.50	-9.52	-8.30	-7.75	-6.86	-6.19
Filing Date Shares Outstanding	122.61	122.61	122.61	122.61	122.61	122.61
Total Common Shares Outstanding	122.61	122.61	122.61	122.61	122.61	122.61
Working Capital	1,552	1,009	1,031	1,093	1,024	865.12
Book Value Per Share	11.77	10.98	10.63	10.18	9.71	8.86
Tangible Book Value	742.89	709.68	673.79	630.44	571.54	461.74
Tangible Book Value Per Share	6.06	5.79	5.50	5.14	4.66	3.77
Machinery	379.96	146.03	109.29	236.64	215.69	194.07
Construction In Progress	16.01	13.18	6.81	14.23	6.22	9.33

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 24, 2026

Data Sources Report a data error